IRA MFP & 340B Rebate Pilot Program Guide & Toolkit

A comprehensive, no-cost resource for covered entities preparing for 2026.

The Inflation Reduction Act's (IRA) Maximum Fair Price (MFP) requirements and HRSA's 340B Rebate Model Pilot Program, effective in 2026, introduce major changes to drug pricing and manufacturer rebate obligations.

This guide consolidates federal updates, operational workflows, rebate mechanics, data requirements, and implementation best practices—all in one place. Virtue created this resource to help covered entities prepare early, understand compliance requirements, and make informed decisions—whether handling the work internally or partnering with expert support.

hero_cover

Why This Matters for Covered Entities

This toolkit is designed for leaders preparing for the combined operational impacts of MFP reimbursement changes and the 340B Rebate Model.

The IRA and rebate pilot program introduce new oversight, reporting, and rebate pathways that directly affect:

  • Drug pricing and ceiling rate alignment

  • Medicaid duplicate discount prevention

  • Rebate invoicing and payment reconciliation

  • Data integrity across retail, specialty, and contract pharmacy networks

  • Manufacturer compliance interaction and audit risks

These shifts require new workflow design, data matching, reconciliation procedures, and cross-stakeholder coordination.

Compliance & Reporting Requirements

Covered entities participating in the rebate model must meet newly defined data, reporting, and submission standards to qualify for rebate payments.

Key Requirements Include:

  • Submission of claims-level data using approved formats

  • Documentation alignment across retail, specialty, and contract pharmacy networks

  • Wholesaler-reported purchase and distribution records matching CE attribution

  • Secure reconciliation workflows that can withstand audit review

Examples of Required Data Fields:

  • NDC-11 and package size

  • Quantity dispensed

  • Date of service / dispense date

  • Prescriber NPI / ordering provider

  • Covered entity 340B identifier

  • Pharmacy location / dispensing site

Submission Timelines:

Data must be submitted within a defined post-dispense window (typically ~45 days, depending on manufacturer plan).

Required Documentation Sources:

  • Contract pharmacy claim files

  • Wholesaler distribution reports

  • CE eligibility documentation

  • Medicaid exclusion / duplicate discount validation files

Operational Framework & Workflows

This section outlines step-by-step models to execute rebate workflows internally with required controls.

Sample Internal Workflow:

  • Capture dispensings across contract & in-house pharmacies
  • Normalize data fields & validate attribution to CE
  • Submit claims to rebate platform
  • Validate manufacturer approval or denial
  • Reconcile rebate payments to transaction-level records
  • Archive documentation for audit readiness

For in-house pharmacies dispensing drugs listed under both MFP and the 340B rebate pilot, entities must determine at the claim level whether the 340B rebate or MFP rebate yields the most optimal financial outcome.

Common Risk Points:

  • Missing prescriber data → invalid rebate claims

  • NDC mismatches due to repackaging or package-size variations

  • Contract pharmacy financial ambiguity → attribution disputes

  • Duplicate-discount risk across Medicaid payers

financial-workflow-analysis

Governance & Oversight Recommendations:

  • Quarterly internal audits

  • Centralized documentation system

  • Separation of duties between finance, compliance, and pharmacy

  • Crosswalk mapping between claims data and purchase data

Financial Modeling & Strategy

This section focuses on financial impacts and forecasting using the rebate model rather than upfront discounts. The workbook tools help organizations model revenue, budget exposure, and scenario outcomes across key pricing benchmarks.

Stage 1: Tools Included in the Workbook

These tools support forecasting, modeling, and year-over-year comparisons:

  • Rebate revenue projection calculator
  • Budget impact forecasting
  • Manufacturer-specific scenario modeling
  • Year-over-year cost comparison charts

The workbook includes side-by-side comparisons of 340B ceiling pricing, MFP reimbursement amounts, and rebate scenarios to identify the most advantageous model for each NDC.

Stage 2: Strategic Applications

Organizations can use these insights to:

  • Forecast cash-flow impact from delayed discounting
  • Evaluate which manufacturers or drugs should be included
  • Assess model participation impact across payers and contract networks
  • Compare financial outcomes under multiple pricing pathways

Stage 3: How Rebate Pricing Works

A simple three-step model guides the financial impact:

  • Stage 1
    WAC Purchase

    Drug purchased upfront at nondiscounted price

  • Stage 2
    Rebate Issued

    Manufacturer reimburses the difference

  • Stage 3
    Net Cost

    Final cost aligns to 340B ceiling price

Specialized 340B Consulting for Complex Operations

Row triangle Shape Decorative svg added to top

Who Is This Resource For

This toolkit supports operational, financial, and compliance leaders across:

  • Covered Entities

  • Pharmacy Directors & 340B Program Managers

  • Compliance & Internal Audit Teams

  • Health System Finance Leadership

  • Manufacturers partnering with 340B entities

Tailored versions may be customized for multi-site systems, national chains, and specialty networks.

hero_cover

How Virtue Can Help

This resource is designed for internal execution, but Virtue offers support for organizations needing advanced implementation.

Operational Support Services Include:

  • Data validation & integrity assessments

  • Duplicate discount prevention strategy

  • Contract pharmacy oversight & modeling

  • Technical + workflow implementation support

  • Advisory collaboration with legal and compliance teams

Support includes analysis of whether MFP or 340B rebate participation provides greater financial stability for each drug and dispensing channel.

Stay on Top of 340B News!

Join the 340B professionals who rely on Virtue 340B Insights for:

 

⚠️ Timely regulatory updates explained with practical guidance so you know exactly how changes affect your program.

📋 Action-ready audit tools like checklists, templates, and monitoring tips designed to strengthen your compliance oversight.

💰 Proven cost-saving insights that help covered entities maximize 340B savings while staying aligned with HRSA expectations.

🎯 Lessons from real-world audits that highlight common pitfalls and provide strategies to avoid costly compliance errors.

 

Subscribe now and stay ahead of the curve – because in 340B compliance, being reactive costs more than being proactive.

Frequently Asked Questions